Valeant Pharmaceuticals

Page 2 of 4

This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
Finance

This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO

By
May 10, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
Finance

Valeant Files Much Delayed Annual Earnings Saying It’s “Cured”

By
April 29, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance

Here’s Why Valeant’s Shares Are Rising

By
April 7, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Bill Ackman Hints Who Valeant’s Next CEO Will Be

By
April 6, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance

Here’s Why Moody’s Just Downgraded Valeant

By
April 1, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Bill Ackman Asked for Information in Drug Pricing Probe

By
March 25, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance

The Really Big Problem with Valeant’s Billions of Debt

By
March 23, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Here’s Why Valeant May Have Accused Its Former CFO of “Improper Conduct”

By
March 22, 2016
Drug Hearing
Finance

Valeant Infighting Is Getting Nasty

By
March 21, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance

This Valeant Investor Is In Even Bigger Trouble than Bill Ackman

By
March 18, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant CEO Promises Company Won’t Go Bankrupt in Staff Memo

By
March 18, 2016
MSMB Capital Management CIO Martin Shkreli
Finance

Even Pharma Bro Martin Shkreli Wouldn’t Touch Valeant

By
March 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant’s Shares Are Having An Epically Bad Day

By
March 15, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health

Valeant Just Slashed Its Profit Guidance

By Reuters and Fortune Editors
March 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Here’s What Valeant’s Earnings Tell Us About the Future of the Drug Maker

By
March 14, 2016

Most Popular